翰森制药:公开B7H3 ADC、B7H4 ADC分子结构

药渡
Jul 18

▎Armstrong2025年7月,翰森制药B7H3 ADC、B7H4 ADC新药的分子结构正式公开。翰森制药B7H3 ADC新药HS-20093通用名为Risvutatug rezetecan,目前处于三期临床阶段。HS-20093的氨基酸序列如下,毒素采用恒瑞的SHR-9265(rezetecan),DAR值为4。HS-20093此前拿下非小细胞肺癌、小细胞肺癌、骨肉瘤的突破疗法。翰森制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10